Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death.
about
The enigma of caspase-2: the laymen's viewProstaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway.Nuclear factor-kappaB inducing kinase is required for graft-versus-host disease.Release of serine/threonine-phosphorylated adaptors from signaling microclusters down-regulates T cell activation.Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistanceHigh-throughput RNAi screening of human kinases identifies predictors of clinical outcome in colorectal cancer patients treated with oxaliplatin.A new look at T cell receptor signaling to nuclear factor-κBPhosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells.Caspases and kinases in a death grip.Germinal center kinases in immune regulation.The SLP-76 Src homology 2 domain is required for T cell development and activation.The HIV-1 gp120/V3 modifies the response of uninfected CD4 T cells to antigen presentation: mapping of the specific transcriptional signature.Functional and biochemical characterization of a T cell-associated anti-apoptotic protein, GIMAP6.Macroautophagy inhibition maintains fragmented mitochondria to foster T cell receptor-dependent apoptosis.Conditional knockout mice reveal an essential role of protein phosphatase 4 in thymocyte development and pre-T-cell receptor signalingPro- and anti-apoptotic CD95 signaling in T cells.The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation.Inhibition of NF-κB induces a switch from CD95L-dependent to CD95L-independent and JNK-mediated apoptosis in T cells.Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response.Sustained JNK signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic differentiation.Exploiting Cell Death Pathways for Inducible Cell Elimination to Modulate Graft-versus-Host-Disease.
P2860
Q24595653-DB61F160-F1B9-4318-A16F-622708A77C55Q30157749-17D77252-A07A-4972-9DD2-7E16E75E32D9Q34371137-0C09BE25-5B83-4396-BD8D-74B2CF581A59Q35670715-17585825-FC0B-444A-BBA9-1B46C1966C62Q35954885-FD1A6FF0-6DA1-4549-A3D1-6053CBB8369FQ36140973-A5C952B8-8341-455D-AB27-AB7A55EB7123Q36906449-ADE5E72A-B38F-4D9E-ACCA-0089CCD59FEDQ37321154-B2A31A2F-6E59-4326-A5A0-2B3EB2995662Q37593693-5C1930D5-E5BF-4E68-8AF1-0534FD9B6637Q37727837-76DB6968-480D-403E-BABC-9760307A9756Q38829466-7B12B517-CAB5-4F4E-B4A4-84442AE9999CQ38849064-984D9C49-1D1E-4251-923F-BA6F6444A081Q38851580-F67E0140-476C-495B-B435-17AEC2AF928AQ41007184-C56A6849-0E85-48DA-9A90-F1E86F2CDAD6Q41780620-47C37EA8-C80D-431F-BE74-8B62DD42223FQ41894662-7BA0D8F0-4E89-4ECD-8DBF-60981402A5F3Q42772785-2F0119A9-3191-45BB-B838-5537BB8345EAQ42848353-7B00212C-4D10-4881-B884-7362DE821711Q42947729-1AD62448-784A-4879-8DCD-811CCA9A70DDQ53595082-47427065-B68B-468B-80FD-52C999837A1AQ55245977-BD3330A0-84CB-47F9-8F67-355E5A7B534D
P2860
Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Activation or suppression of N ...... activation-induced cell death.
@en
type
label
Activation or suppression of N ...... activation-induced cell death.
@en
altLabel
Activation or suppression of N ...... activation-induced cell death
@en
prefLabel
Activation or suppression of N ...... activation-induced cell death.
@en
P2093
P2860
P356
P1433
P1476
Activation or suppression of N ...... activation-induced cell death.
@en
P2093
Alexander Golks
Peter H Krammer
Rüdiger Arnold
P2860
P304
P356
10.1038/SJ.EMBOJ.7600894
P407
P577
2005-12-08T00:00:00Z